Search results (200)
« Back to NewsRDM researchers among world-leading cardiologists at ESC Congress 2024
29 August 2024
World-leading cardiology experts are to convene at the annual European Society of Cardiology (ESC) Congress in London from tomorrow (Friday 30 August).
Of Mice and Men - Researchers demonstrate evolutionary conservation of blood stem cell subtypes
27 August 2024
General MRC MHU MRC WIMM Publication Research
Researchers from the MRC Weatherall Institute of Molecular Medicine (WIMM) have shown that blood stem cell subtypes found in mice also exist in humans. This provides important information for research into therapies to alleviate the negative effects of aging.
Grant awarded to develop artificial intelligence tools to understand the bone marrow landscape
14 August 2024
Our researchers have received $200,000 to develop artificial intelligence tools to better diagnose what goes wrong in the bone marrow of myeloproliferative neoplasm (MPN) patients.
Vote for AI research shortlisted for the BHF Research Story of the Year award
7 August 2024
Voting is open! Some of our British Heart Foundation funded research has been shortlisted for the BHF Research Story of the Year award. Discover more and vote for our work into developing an AI tool to predict people’s risk of having a heart attack years before it happens.
Qiang Zhang appointed Associate Professor of AI in Cardiovascular Imaging
29 July 2024
RDM and the Big Data Institute have appointed Dr Qiang Zhang as Associate Professor of AI in Cardiovascular Imaging.
Experts outline priority areas which should be addressed to advance treatment for inherited lung diseases
29 July 2024
An expert group including Deborah Gill, Professor of Gene Medicine in RDM’s Nuffield Division of Clinical Laboratory Sciences, has published a new position paper which addresses the gaps in research and treatment development for familial pulmonary fibrosis (FPF) – a collection of individually rare and severe genetically inherited lung diseases.
New study finds semaglutide (or ‘Ozempic/Wegovy’) safe for brain health with possible benefits for cognition and nicotine dependence
17 July 2024
Semaglutide – widely known as Ozempic or Wegovy – does not appear to negatively impact brain health and is associated with lower risk of cognitive problems and less nicotine dependence, according to a new study.
Yellowstone Biosciences spinout launches to advance cutting-edge cancer therapies
15 July 2024
General MRC MHU MRC WIMM Research
Yellowstone Biosciences, a biotechnology spinout, has launched to pioneer new cancer treatments using advanced T-cell therapies based on groundbreaking research from the MRC Weatherall Institute of Molecular Medicine at the University of Oxford.
RDM launches new metabolism cross-cutting research theme
12 June 2024
On Monday 10 June, more than 50 members of RDM met to kick off the ‘Metabolism in Molecular Medicine’ cross-cutting research theme.
Heart scans could help thousands avoid unnecessary invasive procedure
5 June 2024
Thousands of patients admitted to hospital every year with suspected heart attacks could avoid an unnecessary invasive procedure if they have a routine heart MRI scan first, according to research led by the Radcliffe Department of Medicine.
AI analysis of routine heart scans can predict risk of a developing heart problems ten years in advance, new research finds
30 May 2024
AMIIC CVM General Publication Research
A research team led by scientists at the Radcliffe Department of Medicine, University of Oxford has developed an Artificial Intelligence (AI) technology which can accurately predict the risk of a heart attack, heart failure or cardiac death from routine cardiac CT scans, up to ten years in advance.
University of Oxford research receives £5 million funding boost from British Heart Foundation
24 May 2024
Funding will support world-leading cardiovascular disease research.
Study outlines feasibility of multiple disease risk prediction model for primary care
23 May 2024
A team of researchers, led by the Radcliffe Department of Medicine, has found that a single, integrated health check carried out in a primary care setting can accurately predict risks for diseases across multiple organs.
Early blood glucose control for people with type 2 diabetes is crucial for reducing complications and prolonging life
18 May 2024
Research led by scientists from the Universities of Oxford and Edinburgh has found that early good blood glucose control can minimise the lifetime risk of diabetes-related complications, including heart attacks, kidney failure and vision loss.
Professor Graham Ogg Receives Wellcome Discovery Award with International Team
16 April 2024
Awards General MRC TIDU MRC WIMM Research
Professor Graham Ogg, from the MRC Weatherall Institute of Molecular Medicine has been awarded funding for an international 8-year research programme from global charitable foundation Wellcome.
UK’s first registry to be set up for those at risk of type 1 diabetes
11 March 2024
Researchers from the Oxford BRC and other collaborating organisations have received funding to set up a UK registry for children and adults who are at risk of type 1 diabetes and have tested positive for diabetes autoantibodies.